Hospital & Healthcare Management May 16, 2022
Content Team

Because of their inexpensive cost, vaccinations made with inactivated SARS-CoV-2 viruses are widely used in underdeveloped countries. As per new research from Sweden’s Karolinska Institutet, a booster shot of mRNA vaccine given after two doses of inactivated vaccination provides the same layer of safety versus COVID-19 as 3 doses of mRNA vaccine. The findings have been published in Nature Communications, one of the journals.

The findings suggest that one booster shot of an mRNA vaccine, in addition to the less expensive but less effective inactivated vaccines, is adequate to attain the ‘gold-standard’ immune reaction calculated after three doses of an mRNA vaccine, says Karolinska Institutet’s Department of Biosciences and Nutrition’s professor Qiang Pan Hammarström. Even in resource-poor countries, which would...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Pharma / Biotech, Trends
Covid’s scientific silver lining: A chance to watch the human immune system respond in real time
How GLP-1’s moved from research labs to national TV
Understanding the politics of drug pricing in the United States
Opinion: Oprah kicked off a national conversation on obesity and GLP-1 drugs. Let’s have it
Brazil’s plan for low-cost CAR-Ts

Share This Article